OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 91 filers reported holding OVID THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,835,000 | -62.2% | 1,540,671 | -55.8% | 1.27% | -63.5% |
| Q2 2022 | $7,499,000 | -43.4% | 3,487,928 | -17.3% | 3.49% | -36.5% |
| Q1 2022 | $13,245,000 | +3.0% | 4,218,069 | +5.3% | 5.49% | -6.9% |
| Q4 2021 | $12,860,000 | +17.7% | 4,006,185 | +23.2% | 5.90% | +18.6% |
| Q3 2021 | $10,930,000 | +39.8% | 3,252,892 | +62.6% | 4.97% | +21.6% |
| Q2 2021 | $7,820,000 | -21.7% | 2,000,000 | -19.5% | 4.09% | -24.2% |
| Q1 2021 | $9,982,000 | – | 2,483,059 | – | 5.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
| BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
| COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
| ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
| Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
| Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
| Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
| Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
| Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |